Ana I. Rodríguez‐Pérez

The inflammatory response in the MPTP model of Parkinson’s disease is mediated by brain angiotensin: relevance to progression of the disease

Belen Joglar, Jannette Rodríguez‐Pallares, Ana I. Rodríguez‐Pérez et al. · Journal of Neurochemistry · 2009 · 192 citations

Life Sciences, Neurobiology, Neuroscience +17

Involvement of PPAR-γ in the neuroprotective and anti-inflammatory effects of angiotensin type 1 receptor inhibition: effects of the receptor antagonist telmisartan and receptor deletion in a mouse MPTP model of Parkinson's disease

Pablo Garrido‐Gil, Belen Joglar, Ana I. Rodríguez‐Pérez et al. · Journal of Neuroinflammation · 2012 · 134 citations · Full text

Medicine, Neuroscience, Pharmacology +17

Bidirectional Neural Interaction Between Central Dopaminergic and Gut Lesions in Parkinson’s Disease Models

Pablo Garrido‐Gil, Ana I. Rodríguez‐Pérez, Antonio Dominguez‐Meijide et al. · Molecular Neurobiology · 2018 · 126 citations

Life Sciences, Neurobiology, Neuroscience +16

Receptor-heteromer mediated regulation of endocannabinoid signaling in activated microglia. Role of CB1 and CB2 receptors and relevance for Alzheimer’s disease and levodopa-induced dyskinesia

Gemma Navarro, Edgar Angelats, Íñigo Etayo et al. · Brain Behavior and Immunity · 2017 · 123 citations

Life Sciences, Neuroscience, Pharmacology +17

New Cyclodextrin Hydrogels Cross-Linked with Diglycidylethers with a High Drug Loading and Controlled Release Ability

Carmen Rodrı́guez-Tenreiro, Carmen Alvarez‐Lorenzo, Ana I. Rodríguez‐Pérez et al. · Pharmaceutical Research · 2005 · 118 citations

Pharmacy, Pharmaceutics, Pharmacology +16